Seeking Alpha

SA author Austrolib provides a run-through of cancer vaccines from the "underwhelming to the...

SA author Austrolib provides a run-through of cancer vaccines from the "underwhelming to the exciting." The latter includes OncoVEX from Amgen (AMGN), which would be a buy if it weren't "skirting its all-time highs of $89 a share." Even more interesting are DCVax-L (brain) and DCVax-Direct (inoperable tumors) from Northwest Biotherapeutics (NWBO.OB). The problem is that Northwest has little cash and lots of debt notes.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)